WARPTECHNEWS · LAB

Home AI Business Tech Archive

Storia: Eli Lilly sues 6 companies over illegal retatrutide sales — Warptech Lab News

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 13 fonti

Eli Lilly sues 6 companies over illegal retatrutide sales

The drug remains in Phase 3 clinical trials and has not been approved by any regulator for human use

Raccontata da

biopharmadive.com

thehindubusinessline.com

morningstar.com

valor.globo.com

www1.folha.uol.com.br

endpoints.news+1 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

qz.comStai leggendo13 h fa

Eli Lilly sues 6 companies over illegal retatrutide sales

The drug remains in Phase 3 clinical trials and has not been approved by any regulator for human use

Timeline cronologica

mercoledì 12 agosto 2026·biopharmadive.com
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide
Ahead of an approval filing, the drugmaker is amping up a fight against sellers who claim to offer versions of its highly anticipated “triple-G” weight loss medicine.
mercoledì 12 agosto 2026·thehindubusinessline.com
Eli Lilly escalates fight against black market weight-loss medicines
The drug company said Wednesday that it planned to file lawsuits against US businesses that sell retatrutide products illegally, and it’s asking regulators to do more to rein in…

14 h fa

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide

The lawsuits target a range of businesses that allegedly marketed ⁠retatrutide products to consumers despite the drug remaining under clinical development.

Leggi questa versione → originale

cbsnews.com14 h fa

Eli Lilly takes aim at illicit market for its experimental weight-loss drug

The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.

Leggi questa versione → originale

benzinga.com9 h fa

Eli Lilly Escalates Retatrutide Fight, Reports 200-Plus Illegal Sellers to Authorities - Eli Lilly (NYSE:

Eli Lilly filed six lawsuits against U.S. entities for illegally selling unapproved retatrutide, warning consumers of serious health risks.

Leggi questa versione → originale

thehindubusinessline.com15 h fa

Eli Lilly escalates fight against black market weight-loss medicines

The drug company said Wednesday that it planned to file lawsuits against US businesses that sell retatrutide products illegally, and it’s asking regulators to do more to rein in the illicit market

Leggi questa versione → originale

endpoints.news8 h fa

Eli Lilly files first lawsuits over retatrutide 'black market'

Eli Lilly sued six US compounding pharmacies for illegally selling unapproved retatrutide.

Leggi questa versione → originale

mercoledì 12 agosto 2026·

cbsnews.com

Eli Lilly takes aim at illicit market for its experimental weight-loss drug

The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.

mercoledì 12 agosto 2026·

morningstar.com

Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market

Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market

mercoledì 12 agosto 2026·

cnbc.com

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide

The lawsuits target a range of businesses that allegedly marketed ⁠retatrutide products to consumers despite the drug remaining under clinical development.

mercoledì 12 agosto 2026·

qz.com

Eli Lilly sues 6 companies over illegal retatrutide sales

The drug remains in Phase 3 clinical trials and has not been approved by any regulator for human use

mercoledì 12 agosto 2026·

valor.globo.com

Eli Lilly processa seis empresas por venda clandestina de seu remédio experimental para emagrecimento

Farmacêutica alega que as entidades comercializam a retatrutida, um medicamento baseado na enzima GLP-1 que ainda está em fase de testes clínicos de Fase 3 e não foi aprovado pela…

mercoledì 12 agosto 2026·

www1.folha.uol.com.br

Eli Lilly processa seis empresas nos EUA por venda ilegal de retatrutida, molécula ainda em pesquisa

Ações miram farmácias de manipulação, clínicas de estética, spas médicos e vendedores online

mercoledì 12 agosto 2026·

statnews.com

Pharmalittle: We're reading about Lilly 'black market' lawsuits, pushback over Trump vaccine plan, and more

Eli Lilly filed six lawsuits against U.S. companies it accuses of illegally selling black-market versions of its experimental obesity drug retatrutide

mercoledì 12 agosto 2026·

fortune.com

Lilly escalates its fight against black market weight-loss shots | Fortune

Knockoff versions of the company's weight-loss drug raise concerns, citing a "public health crisis."

mercoledì 12 agosto 2026·

benzinga.com

Eli Lilly Escalates Retatrutide Fight, Reports 200-Plus Illegal Sellers to Authorities - Eli Lilly (NYSE:

Eli Lilly filed six lawsuits against U.S. entities for illegally selling unapproved retatrutide, warning consumers of serious health risks.

mercoledì 12 agosto 2026·

endpoints.news

Eli Lilly files first lawsuits over retatrutide 'black market'

Eli Lilly sued six US compounding pharmacies for illegally selling unapproved retatrutide.

giovedì 13 agosto 2026·

expansion.com

Lilly demanda a seis firmas por copias de su antiobesidad

Lilly ha presentado demandas contra seis empresas estadounidenses a las que acusa de vender ilegalmente versiones en el mercado negro de Retatrutida, su f�rmaco contra la…